Skip to playerSkip to main contentSkip to footer
  • 9/23/2022
Patients were injected with a drug that was a weakened form of the cold sore virus - herpes simplex - that has been modified to kill tumours. The study lead said it was rare to see such a good response at such an early stage.

VIEW MORE : https://bit.ly/1breakingnews

Recommended